Videos
Advertisement
Dr. Liu unpacks the trial results, the recent approval, and the unique biomarker testing considerations for NRG1 fusions.
Dr. Anne Marie Morse discusses the troubling connection between sleep disorders and dementia.
Thomas Ruggia, CEO of Samsara Vision, talks about a novel implantation device for age-related macular degeneration.
Nephrology Times spoke with Amber Sanchez, MD, about the use of apheresis in nephrology.
The 12-member board will guide the guide the patient-driven organization’s research and strategic priorities.
Mara B. Antonoff, MD, FACS, discusses what could be on the horizon for surgery in stage IV lung cancer.
Dr. Cytryn summarizes a trial in progress investigating a novel immunotherapy combination for gastroesophageal adenocarcinoma
Dr. Merritt shares new thoracic surgery research insights for patient selection in sublobar resection for early-stage NSCLC.
Dr. Kevin Alexander speaks with The CardioNerds about the importance of providing swift treatment to patients with ATTR-CM.
Dr. J.Quentin Clemens talks about the current treatment landscape around interstitial cystitis.
Larry Lipshultz, MD, discusses the concurrent use of testosterone replacement therapy, especially as it pertains to couples.
The study is evaluating a prophylactic dermatologic regimen in patients receiving amivantamab plus lazertinib.
Dr. Seder discusses the real-world study he presented at STS 2025, which addressed key questions about long-term outcomes.
Clinical Considerations Surrounding Sublobar Resection in NSCLC: Dr. Merritt Discusses Recent Review
Robert E. Merritt, MD, MBA, FACS, shares insights on his systematic review of sublobar resection and lobectomy. 
Mara B. Antonoff, MD, FACS, shares key considerations and developments in surgery for stage IV lung cancer.
Aliya Omer, AstraZeneca, talks about data that backs the efficacy of olaparib in treating high-risk early breast cancer.
Dr. Liu discusses remaining questions, key considerations, and how the data might shape the field moving forward.
Wei Ling Lau, MD, discussed the potential impact of AccurKardia's AK+ Guard hyperkalemia detection software.
Dr. Liu shares his insights on the recent announcement that the phase 3 trial met its secondary endpoint of overall survival.
Dr. Adam Brufsky details to Dr. Karine Tawagi what separates SABCS from other conferences when it comes to breast cancer.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.